What is a concise protocol for ovulation induction?

Ovulation Induction: Concise Protocol

Primary Approach by Etiology

For PCOS (Most Common Indication)

Start with clomiphene citrate as first-line pharmacological treatment, achieving 80% ovulation rates and 50% conception rates 1. This represents the most evidence-based initial approach for women with PCOS attempting conception.

Protocol sequence:

• Lifestyle modification first: Weight loss of 5-10% improves ovulation and pregnancy rates 2, 3. Begin with calorie-restricted diet (500-700 kcal/day deficit) and 150 minutes/week moderate-intensity exercise 2
• Clomiphene citrate: Standard starting dose, typically 50mg days 3-7 of cycle
• If clomiphene fails: Use low-dose gonadotropin step-up protocol starting at 37.5-50 IU/day FSH for up to 14 days with close monitoring, maximum 6 cycles 2. Low-dose protocols achieve high monofollicular development rates with lower ovarian hyperstimulation risk 1
• Alternative second-line: Letrozole has emerged as preferred over clomiphene in recent guidelines 2
• Last resort: IVF with GnRH antagonist protocols plus metformin to reduce hyperstimulation risk 2

Critical caveat: Do not attempt ovulation induction if BMI >35 kg/m² until weight reduction achieved 2.

For Functional Hypothalamic Amenorrhea (FHA)

Use pulsatile GnRH as first-line when available, followed by gonadotropins when GnRH unavailable 4. This is the gold standard for FHA-related anovulation.

Protocol sequence:

• Prerequisite: Ensure BMI ≥18.5 kg/m² before any ovulation induction 5
• First-line: Pulsatile GnRH therapy achieves 96% cumulative conception after 6 cycles, 75% ovulation rates, only 3.8% multiple pregnancy risk 4. However, GnRH currently unavailable in United States 4
• Second-line: Gonadotropins (HMG containing both FSH and LH activity preferred, as women with FHA require both) 4. Use cautiously due to higher multiple pregnancy risk (14.8% vs 8.3% with GnRH) 4
• Limited option: Clomiphene citrate trial only if sufficient endogenous estrogen present, though success uncertain 4, 5

Important distinction: If FHA with polycystic ovarian morphology (FHA-PCOM), pulsatile GnRH remains equally effective with similar ovulation rates (80.8% vs 77.7%) and no increased hyperstimulation risk at equivalent doses 5.

For Clomiphene-Resistant Cases

Switch to gonadotropins using low-dose step-up protocol rather than continuing clomiphene 6. The evidence shows gonadotropins probably result in 24% more live births than continued clomiphene (RR 1.24,95% CI 1.05-1.46) 6.

Gonadotropin selection:

• rFSH vs urinary gonadotropins: Little or no difference in live birth, multiple pregnancy, or clinical pregnancy rates 6. Choose based on availability and cost
• Starting dose: 37.5-50 IU/day FSH, increase incrementally if no response after 14 days 2, 7
• Monitoring: Close ultrasound and estradiol monitoring essential to prevent hyperstimulation

Key Monitoring Parameters

Essential surveillance:

• Follicle size and number via transvaginal ultrasound
• Serum estradiol levels
• Cancel cycle if >3 follicles develop to prevent high-order multiples 4
• Maximum 6 stimulation cycles per protocol 2

Critical Pitfalls to Avoid

1. Never induce ovulation in obese women (BMI >35) with PCOS without weight loss first - contraindicated 2
2. Never use high-dose gonadotropin protocols - low-dose step-up reduces hyperstimulation risk while maintaining efficacy 1, 2
3. Do not use metformin as first-line for ovulation induction - insufficient evidence for fertility improvement, though may help metabolic parameters 3
4. Avoid oral contraceptives in FHA for menstrual regulation - masks return of spontaneous menses and bone loss continues 4
5. Stop metformin once pregnancy confirmed if used during induction 2

Special Considerations

For women >35 years or poor responders: Consider delayed GnRH antagonist protocol with high-dose rFSH plus clomiphene citrate, which achieves lower cancellation rates (4.7% vs 34%) and higher pregnancy rates (22.2% vs 15.3%) compared to standard long protocols 8.

Intrauterine insemination: Can be combined with ovulation induction protocols, though specific benefit varies by underlying diagnosis 9.